Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients <it>in vivo</it>: results from a randomized clinical trial of IL-2 with or without histamine... by Gehlsen K, Thiel E, Hellstrand K, Letsch A, Scheibenbogen C, Asemissen AM, Keilholz U

Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versu... by Middleton, M, Hauschild, A, Thomson, D, Anderson, R, Burdette-Radoux, S, Gehlsen, K, Hellstrand, K, Naredi, P

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chron... by Romero, A, Lagging, M, Westin, J, Dhillon, A, Dustin, L, Pawlotsky, J, Neumann, A, Ferrari, C, Missale, G, Haagmans, B, Schalm, S, Zeuzem, S, Negro, F, Verheij-Hart, E, Hellstrand, K